TUBA1A
Basic information
Region (hg38): 12:49184686-49189324
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal dominant 40 (Definitive), mode of inheritance: AD
- lissencephaly due to TUBA1A mutation (Definitive), mode of inheritance: AD
- lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
- lissencephaly due to TUBA1A mutation (Supportive), mode of inheritance: AD
- tubulinopathy-associated dysgyria (Supportive), mode of inheritance: AD
- lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
- lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
- tubulinopathy (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lissencephaly 3 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 17218254; 17584854; 18728072; 18954413; 21403111; 22264709; 22633752; 22948023; 23317684; 23528852; 23361065 |
ClinVar
This is a list of variants' phenotypes submitted to
- Tubulinopathy (40 variants)
- Lissencephaly due to TUBA1A mutation (14 variants)
- not provided (13 variants)
- Lissencephaly (3 variants)
- Inborn genetic diseases (3 variants)
- Lissencephaly type 3 (2 variants)
- Tubulinopathy-associated dysgyria (2 variants)
- Cerebral palsy (1 variants)
- Congenital bilateral perisylvian syndrome (1 variants)
- TUBA1A-associated tubulinopathy (1 variants)
- Tubulinopathy-associated dysgyria;West syndrome (1 variants)
- Congenital fibrosis of extraocular muscles;Congenital bilateral perisylvian syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBA1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 57 | 66 | ||||
missense | 52 | 100 | 57 | 210 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 6 | 8 | ||
non coding | 18 | 28 | ||||
Total | 54 | 108 | 63 | 76 | 13 |
Variants in TUBA1A
This is a list of pathogenic ClinVar variants found in the TUBA1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-49184799-T-C | Likely benign (Jun 14, 2018) | |||
12-49185008-CT-C | not specified | Likely benign (Nov 19, 2019) | ||
12-49185019-C-T | Likely benign (Jan 19, 2024) | |||
12-49185024-CT-C | Tubulinopathy | Likely pathogenic (Jul 01, 2018) | ||
12-49185037-C-T | Benign (Oct 20, 2018) | |||
12-49185059-C-T | Tubulinopathy • TUBA1A-associated tubulinopathy | Pathogenic/Likely pathogenic (Jul 29, 2021) | ||
12-49185060-C-G | Tubulinopathy | Pathogenic (Jul 01, 2018) | ||
12-49185062-A-G | Lissencephaly due to TUBA1A mutation • Tubulinopathy | Likely pathogenic (Jul 01, 2018) | ||
12-49185062-ACCT-A | not specified • Lissencephaly;Polymicrogyria • Inborn genetic diseases | Uncertain significance (Apr 09, 2021) | ||
12-49185063-CCTCCTCATAATCCTT-C | Lissencephaly due to TUBA1A mutation | Pathogenic (Sep 26, 2019) | ||
12-49185075-C-T | Uncertain significance (Jul 01, 2018) | |||
12-49185081-C-G | Tubulinopathy | Pathogenic (Jul 01, 2018) | ||
12-49185083-A-T | Uncertain significance (Feb 06, 2022) | |||
12-49185090-C-T | Uncertain significance (May 12, 2022) | |||
12-49185092-A-T | Lissencephaly due to TUBA1A mutation • Tubulinopathy | Pathogenic/Likely pathogenic (Jul 01, 2018) | ||
12-49185098-T-C | Lissencephaly due to TUBA1A mutation | Likely pathogenic (Mar 23, 2023) | ||
12-49185100-A-C | Benign (Dec 02, 2023) | |||
12-49185101-C-T | Lissencephaly due to TUBA1A mutation • Tubulinopathy • Lissencephaly | Pathogenic (Jun 03, 2022) | ||
12-49185102-G-A | Lissencephaly due to TUBA1A mutation • Inborn genetic diseases • Tubulinopathy | Pathogenic (Dec 19, 2023) | ||
12-49185102-G-T | Tubulinopathy-associated dysgyria | Pathogenic (Nov 01, 2021) | ||
12-49185103-G-A | Likely benign (Dec 02, 2021) | |||
12-49185105-C-T | Lissencephaly due to TUBA1A mutation | Likely pathogenic (May 28, 2019) | ||
12-49185109-T-C | not specified | Likely benign (Mar 10, 2016) | ||
12-49185110-G-A | Lissencephaly due to TUBA1A mutation • Tubulinopathy | Pathogenic/Likely pathogenic (Jul 22, 2022) | ||
12-49185118-A-G | not specified • TUBA1A-related disorder | Conflicting classifications of pathogenicity (Oct 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TUBA1A | protein_coding | protein_coding | ENST00000301071 | 4 | 4529 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.967 | 0.0334 | 125720 | 0 | 1 | 125721 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.58 | 7 | 261 | 0.0268 | 0.0000155 | 2964 |
Missense in Polyphen | 1 | 119.15 | 0.0083928 | 1437 | ||
Synonymous | -0.775 | 104 | 94.4 | 1.10 | 0.00000507 | 898 |
Loss of Function | 3.34 | 1 | 15.0 | 0.0669 | 8.32e-7 | 178 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.;
- Disease
- DISEASE: Lissencephaly 3 (LIS3) [MIM:611603]: A classic type lissencephaly associated with psychomotor retardation and seizures. Features include agyria or pachygyria or laminar heterotopia, severe mental retardation, motor delay, variable presence of seizures, and abnormalities of corpus callosum, hippocampus, cerebellar vermis and brainstem. {ECO:0000269|PubMed:17584854, ECO:0000269|PubMed:25818041}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Tight junction - Homo sapiens (human);Phagosome - Homo sapiens (human);Gap junction - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Apoptosis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in squamous cell - TarBase;Pathogenic Escherichia coli infection;Parkin-Ubiquitin Proteasomal System pathway;stathmin and breast cancer resistance to antimicrotubule agents;downregulated of mta-3 in er-negative breast tumors;Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;TCR;Formation of tubulin folding intermediates by CCT/TriC;p73 transcription factor network;Carboxyterminal post-translational modifications of tubulin;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Protein folding;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Prefoldin mediated transfer of substrate to CCT/TriC;Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding;Post-chaperonin tubulin folding pathway;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Intolerance Scores
- loftool
- 0.278
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.42
Haploinsufficiency Scores
- pHI
- 0.926
- hipred
- Y
- hipred_score
- 0.771
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.681
Mouse Genome Informatics
- Gene name
- Tuba1a
- Phenotype
- growth/size/body region phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- tuba1a
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- dead
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process;regulation of G2/M transition of mitotic cell cycle;cytoskeleton-dependent intracellular transport;regulation of synapse organization;cell division;ciliary basal body-plasma membrane docking
- Cellular component
- nucleus;cytoplasm;cytosol;microtubule;cytoplasmic microtubule;microtubule cytoskeleton;neuromuscular junction;cytoplasmic ribonucleoprotein granule;myelin sheath;membrane raft;recycling endosome;extracellular exosome
- Molecular function
- GTPase activity;structural molecule activity;structural constituent of cytoskeleton;protein binding;GTP binding;protein domain specific binding